Brevan Howard Capital Management’s Avidity Biosciences RNA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-32,712	Closed	-$951K	–	1364
2024 Q4	$951K	Buy	32,712 +26,984	+471%	+$785K	0.01%	417
2024 Q3	$263K	Buy	+5,728	New	+$263K	﹤0.01%	848
2024 Q1	–	Sell	-12,380	Closed	-$112K	–	1253
2023 Q4	$112K	Buy	+12,380	New	+$112K	﹤0.01%	899